Nav: Home

A lot of blood, for no reason? Review shows that common, costly clot test has few benefits

November 02, 2016

ANN ARBOR, Mich. -- A half billion dollars - at least -- gets spent each year on blood tests to see which hospital patients have a genetic quirk that makes their blood more likely to form dangerous clots.

And most of that spending probably isn't necessary, according to a new paper by a University of Michigan Medical School team.

Writing in the Journal of Hospital Medicine, they review what's known about testing for the trait called inherited thrombophilia, and call for a drastic cut in the test's use by doctors across America.

After all, they write, hospitalized people who have already had such dangerous clots, called venous thromboembolisms or VTEs, don't need a positive genetic test to justify taking medication and making other changes to prevent future ones.

And there's no evidence that medication to prevent clots will help hospital patients who haven't yet had a VTE. Testing their DNA for inherited thrombophilia won't change that.

In other words, the authors say, ordering inherited thromboembolism testing on inpatients is something doctors do for little or no reason. And according to the team's analysis of data pulled from medical records, they do it hundreds of thousands of times a year in Medicare patients alone.

Often, it appears, the test gets ordered to satisfy curiosity about why a patient had a VTE, to see if they're among the seven percent of Americans with a genetic mutation that makes blood more prone to clot.

There are several tests for several traits, so patients often get them in combination - what's called a "hypercoagulable workup." But if doctors are following guidelines grounded in evidence, the test result should rarely change a patient's care.

So, except in very specific cases where such clots are highly likely - such as women with a family history of clots who are pregnant or getting hormone replacement therapy - there's probably not much reason to do the test at all.

Resisting temptation

"More testing is not always better," says Christopher Petrilli, M.D., an assistant professor of internal medicine at U-M and co-first author of the new paper.

"Testing for this disorder is almost never beneficial, and in fact can even be harmful because it can cause undue psychological distress for the patient, and unnecessary expense for the healthcare system," he adds.

"Physicians and patients should resist the temptation to perform costly search for an underlying genetic cause of venous thrombosis," says co-first author Lauren Heidemann, M.D., also an assistant professor of medicine.

Petrilli and Heidemann - both hospitalists who specialize in treating patients in the U-M Health System's University Hospital -- have set out to address such "no reason" testing at UMHS and beyond.

They've co-founded a local chapter of the group Providers for Responsible Ordering, which aims to help physicians, nurse practitioners and physician assistants reduce over-testing and use health care resources appropriately.

They've also led the effort to make UMHS one of more than 40 founding members of the High Value Practice Academic Research Alliance, which is working to bring institutions together to help one another implement strategies that make better use of resources.

The current climate of public attention on new genetic testing options and personalized medicine could make this difficult in some cases, they note in the paper.

Ideally, genetic tests to find out whether someone carries a certain genetic trait should be used when there's clear information about the risks, benefits and costs of that test.

"With national health care spending reaching an unsustainable level, we as physicians need to be vigilant about becoming stewards of health care resources," says Heidemann.

Reviewing the evidence

For the paper, Petrilli, Heidemann and their colleagues reviewed the full scope of literature and established guidelines on inherited thrombophilia testing. They illustrated the situation by applying this information to a hypothetical case of a young patient with a VTE but no family history who suffers a pulmonary embolism - a dangerous health emergency where clots form in the lower extremities and travel to the lungs, potentially cutting off oxygen to the body unless treatment starts quickly.

They note the conclusions about VTE prevention and treatment that have been reached by several medical bodies - including an American College of Chest Physicians guideline recommending against giving clot-prevention medication to people with the genetic trait but no VTE history.
-end-
A group that looks at genetic testing, the Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group, concluded that tests for inherited thrombophilia were likely not cost-effective.

In addition to Petrilli and Heidemann, the research team included senior author Vineet Chopra, M.D., M.Sc., a hospitalist and assistant professor of general medicine, as well as assistant professor Megan Mack, M.D. and UMHS financial analyst Paul Durance, Ph.D. Petrilli, Heidemann and Chopra are members of the U-M Institute for Healthcare Policy and Innovation.

The new paper is part of the Journal of Hospital Medicine's series called Choosing Wisely: Things We Do for No Reason. It's published in the November 2016 issue. Reference: J. Hosp. Med., 11: 801-804. doi:10.1002/jhm.2616

University of Michigan Health System

Related Medication Articles:

Self-medication misuse is high in the Middle East
A new review indicates that there is a massive problem of self-medication misuse in the Middle East.
Another step in understanding antipsychotic medication
Antipsychotic drugs are used for the treatment of mental illnesses such as bipolar disorder and schizophrenia.
What impact do medication errors have on nursing home residents?
A new analysis points to surprisingly low rates of serious impacts from medication errors affecting nursing home residents, despite the fact that these errors remain fairly common.
Medication against schizophrenia inhibits pancreatic cancer
Scientists from the German Cancer Research Center, Heidelberg, and from McGill University, Montreal, Canada, have discovered that a receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer.
U-M study highlights multiple factors of ADHD medication use
Youth who take Ritalin, Adderall or other stimulant medications for ADHD over an extended period of time early in life are no more at risk for substance abuse in later adolescence than teens without ADHD, according to a University of Michigan study.
Teen suicide: ADHD medication as prevention
Black-box warnings about the dangers of attention-deficit hyperactivity disorder (ADHD) medications are confusing and could have serious consequences for the risk of youth suicide, according to researchers at the Institut universitaire en santé mentale de Montréal (CIUSSS de l'Est-de-l'Île-de-Montréal) and the University of Montreal.
Does text messaging help with medication adherence in chronic disease?
Medication adherence in chronic disease is poor. Can telephone text messaging help with adherence?
RNs more likely to identify high-risk medication discrepancies
Researchers at the University of Missouri have found that RNs are more likely than LPNs to identify high-risk medication discrepancies, suggesting RNs are better equipped to assess and identify medication errors that could pose risks to residents' safety.
After hip-replacement surgery, medication use decreases
A new study in the journal PAIN® provides information on the trajectories of prescription drug use before and after hip-replacement surgery -- total hip arthroplasty (THA), one of the most common types of joint replacement surgery.
Blood pressure medication can't undo all damage
Patients on antihypertensive medications are still at greater risk of cardiovascular disease, despite controlled numbers.

Related Medication Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".